bioAffinity Technologies, Inc.·4

Jan 24, 8:52 PM ET

DIAMOND STUART 4

4 · bioAffinity Technologies, Inc. · Filed Jan 24, 2024

Insider Transaction Report

Form 4
Period: 2023-10-01
Transactions
  • Award

    Common Stock

    2023-10-01$1.58/sh+11,867$18,75044,340 total
  • Award

    Common Stock

    2024-01-01$1.48/sh+12,668$18,74957,008 total
Footnotes (2)
  • [F1]Represents a grant from the Issuer to Mr. Diamond of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
  • [F2]Represents a grant from the Issuer to Mr. Diamond of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year

Documents

2 files